Cargando…
Adjuvant Bidirectional Chemotherapy Using an Intraperitoneal Port
Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) have been established as treatment options for patients with peritoneal metastases or peritoneal mesothelioma. However, this novel treatment strategy remains associated with a large percentage of local-regional treatme...
Autores principales: | Sugarbaker, Paul H., Bijelic, Lana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3409540/ https://www.ncbi.nlm.nih.gov/pubmed/22888340 http://dx.doi.org/10.1155/2012/752643 |
Ejemplares similares
-
Adjuvant Bidirectional Chemotherapy with Intraperitoneal Pemetrexed Combined with Intravenous Cisplatin for Diffuse Malignant Peritoneal Mesothelioma
por: Bijelic, Lana, et al.
Publicado: (2012) -
Hyperthermic Intraperitoneal Chemotherapy with Melphalan: A Summary of Clinical and Pharmacological Data in 34 Patients
por: Bijelic, Lana, et al.
Publicado: (2012) -
Intraperitoneal Gemcitabine Chemotherapy Treatment for Patients with Resected Pancreatic Cancer: Rationale and Report of Early Data
por: Sugarbaker, Paul H., et al.
Publicado: (2011) -
Systemic Chemotherapy prior to Cytoreductive Surgery and HIPEC for Carcinomatosis from Appendix Cancer: Impact on Perioperative Outcomes and Short-Term Survival
por: Bijelic, Lana, et al.
Publicado: (2012) -
Perioperative intraperitoneal chemotherapy for peritoneal surface malignancy
por: Yan, Tristan D, et al.
Publicado: (2006)